E115: Benralizumab for EGPA - the MANDARA Study
- Author
- Michael Putman
- Published
- Mon 28 Oct 2024
- Episode Link
- https://msputman.podbean.com/e/e115-benralizumab-for-egpa-the-mandara-study/
Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.
MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155
